Navigare Ventures: Seed to Series A

Investment focus

Investment stages

Geographic focus

Nordics
Europe

Inferred thesis

Auto-generated from public data. Not the firm's stated position.

Navigare Ventures appears to focus on early-stage deep technology companies in Northern Europe, with recent portfolio activity suggesting a concentration in biotech applications and advanced materials or semiconductor hardware. The disclosed check size of €1.5M–€3.0M and seed to Series A stage preference indicate positioning as a specialized early-stage investor backing capital-intensive, science-driven ventures.

Generated 14 Oct 2026 from disclosed sectors, stages, and portfolio companies. Is this your firm? Claim the profile to correct it.

How to Pitch Navigare Ventures

No stated policy
Navigare Ventures hasn't published an outreach policy. A short, specific cold email is the safest default.
Source

Portfolio highlights

Elypta - liquid biopsy
EnginZyme - biomanufacturing
SweGaN - GaN semiconductors

Focus and check size from the firm's website. Website reachable as of Sept 2026.

Ready to reach Navigare Ventures?

Red-pen your deck first so the gaps are fixed before they read it. A fit check then scores your pitch against their thesis, stage and ticket, and an email draft uses their real deals and thesis, not a template.